This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Induced-Proximity Leaders

⏳ EARLYBIRD ENDS IN...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 24th-25th, 2024
San Diego Convention CenterSan Diego, USA
June 24th-25th, 2024
San Diego Convention Center,
San Diego, USA

DRIVING INNOVATION AND COMMERCIALIZATION OF INDUCED-PROXIMITY DRUGS

Join key stakeholders to help shape the scientific landscape, assess the latest technologies, their potential and the collaborations and partnerships needed to bring new modalities to market

Pathways & Target Agents

•  Protein Degradation  •  Protein Inhibition  •  Protein Stabilization  •  Cell Therapy Switches  •  Cooperative PPIs  •  Ternary Complexes  •  E3 Ligases  •  Ubiquitination  •  Lysosome  •  Protein Homeostasis

Induced-Proximity Leaders Pathways and target agents
Induced-Proximity Leaders Modalities

Modalities

•  Degraders •  PROTAC •  Molecular Glues •  Antibody Conjugates •  Dimers •  Aptamers •  RIPTAC •  DUBTAC •  Macrocycles •  xTAGs •  LYTAC •  AUTAC •  KineTAC •  RiboTAC •  PhosTAC •  Nanobody Carriers •  Guide RNA •  IMiDs •  Heterobifunctional Molecules •  SERDs

HELP BUILD THE INDUCED-PROXIMITY MARKET

Building on the inaugural Induced-Proximity Leaders roundtable in June 2023 we’re now opening the doors to wider stakeholder groups to help drive the industry

Targeted Protein Degradation and Beyond!

Deep dive into bifunctional, molecular glue and biological entities that can be applied to induced-proximity pathways including proteasome degradation, lysosome degradation, protein inhibition, cell therapy switches and protein stabilization.

Translate Induced-Proximity Discovery to the Clinic

Assess and engage with Biotech leaders focused on identifying clinically viable targets by developing new cooperative protein platforms and integrating rational and AI design processes. As well as learning from degrader pioneers about commercial dynamics to progress an NCE into the clinic successfully.

Find the right Industry Partner and Investment

Connect with Investors and Pharmaceutical business development leads who are actively involved in the space to understand how they are assessing and backing these novel modalities targeting ‘hard-to-drug’ proteins and new PPI pathways via the forum sophisticated 1:1 partnering system, and interactive roundtables.

Ways to Attend

Induced-Proximity Leaders is the event driving the future of Induced-Proximity development by bringing together the most innovative companies with the right partners.

ATTEND AS A DELEGATE

Connect with new peers for two days of productive partnering, expert panels, and networking opportunities with some of the brightest minds in life sciences.

PRESENT YOUR COMPANY

Take the opportunity to showcase your breakthroughs to an audience of potential partners!

JOIN AS AN INVESTOR

Qualified investors and research analysts are invited to request a complimentary registration to attend Induced-Proximity Leaders

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

To begin building your custom sponsorship package today, contact:

Martha Phillips martha@lsxleaders.com

Induced-Proximity Leaders ... The Numbers

150+

Attendees

30+

Speakers

15+ Hours

Networking

1:1

Partnering

1

Innovation Zone

10+

Partners

We do not share any data without consent

Outside vendors who contact you to sell attendee lists are operating independently and without approval of the event organisers.